-
1
-
-
84890503612
-
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1459-1581
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
2
-
-
84890473532
-
The Concise Guide to PHARMACOLOGY 2013/14: Nuclear hormone receptors
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Nuclear hormone receptors. Br J Pharmacol 170: 1652-1675.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1652-1675
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
3
-
-
84890540333
-
The Concise Guide to PHARMACOLOGY 2013/14: Catalytic receptors
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic receptors. Br J Pharmacol 170: 1676-1705.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1676-1705
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
4
-
-
84890472386
-
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013d). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1797-1867
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
5
-
-
84867573089
-
S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility
-
Anstee QM, Day CP, (2012). S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J Hepatol 57: 1097-1109.
-
(2012)
J Hepatol
, vol.57
, pp. 1097-1109
-
-
Anstee, Q.M.1
Day, C.P.2
-
6
-
-
33646080830
-
LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: Dependence on feeding period
-
Asada K, Kotake Y, Asada R, Saunders D, Broyles RH, Towner RA, et al. (2006). LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol 2006: 17142.
-
(2006)
J Biomed Biotechnol
, vol.2006
, pp. 17142
-
-
Asada, K.1
Kotake, Y.2
Asada, R.3
Saunders, D.4
Broyles, R.H.5
Towner, R.A.6
-
7
-
-
40149092689
-
Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo
-
Ateeq B, Unterberger A, Szyf M, Rabbani SA, (2008). Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo. Neoplasia 10: 266-278.
-
(2008)
Neoplasia
, vol.10
, pp. 266-278
-
-
Ateeq, B.1
Unterberger, A.2
Szyf, M.3
Rabbani, S.A.4
-
8
-
-
38549085667
-
The bone microenvironment in metastasis; What is special about bone?
-
Bussard KM, Gay CV, Mastro AM, (2008). The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev 27: 41-55.
-
(2008)
Cancer Metastasis Rev
, vol.27
, pp. 41-55
-
-
Bussard, K.M.1
Gay, C.V.2
Mastro, A.M.3
-
9
-
-
4444326415
-
Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications
-
Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D, et al. (2004). Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 1345-1356.
-
(2004)
Cancer
, vol.101
, pp. 1345-1356
-
-
Chen, G.1
Shukeir, N.2
Potti, A.3
Sircar, K.4
Aprikian, A.5
Goltzman, D.6
-
10
-
-
33745821237
-
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
-
Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA, (2006). Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107: 289-298.
-
(2006)
Cancer
, vol.107
, pp. 289-298
-
-
Chen, G.1
Sircar, K.2
Aprikian, A.3
Potti, A.4
Goltzman, D.5
Rabbani, S.A.6
-
11
-
-
84891349423
-
Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2′-deoxycytidine
-
Chik F, Machnes Z, Szyf M, (2014). Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2′-deoxycytidine. Carcinogenesis 35: 138-144.
-
(2014)
Carcinogenesis
, vol.35
, pp. 138-144
-
-
Chik, F.1
Machnes, Z.2
Szyf, M.3
-
12
-
-
0038080948
-
The methyl donor S-adenosylmethionine inhibits active demethylation of DNA: A candidate novel mechanism for the pharmacological effects of S-adenosylmethionine
-
Detich N, Hamm S, Just G, Knox JD, Szyf M, (2003). The methyl donor S-adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-adenosylmethionine. J Biol Chem 278: 20812-20820.
-
(2003)
J Biol Chem
, vol.278
, pp. 20812-20820
-
-
Detich, N.1
Hamm, S.2
Just, G.3
Knox, J.D.4
Szyf, M.5
-
13
-
-
70350541138
-
STAT3 as a central regulator of tumor metastases
-
Devarajan E, Huang S, (2009). STAT3 as a central regulator of tumor metastases. Curr Mol Med 9: 626-633.
-
(2009)
Curr Mol Med
, vol.9
, pp. 626-633
-
-
Devarajan, E.1
Huang, S.2
-
14
-
-
84856555311
-
A DNA methylation fingerprint of 1628 human samples
-
Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, et al. (2012). A DNA methylation fingerprint of 1628 human samples. Genome Res 22: 407-419.
-
(2012)
Genome Res
, vol.22
, pp. 407-419
-
-
Fernandez, A.F.1
Assenov, Y.2
Martin-Subero, J.I.3
Balint, B.4
Siebert, R.5
Taniguchi, H.6
-
15
-
-
77950574195
-
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth
-
Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, et al. (2010). Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am J Pathol 176: 1959-1972.
-
(2010)
Am J Pathol
, vol.176
, pp. 1959-1972
-
-
Gu, L.1
Dagvadorj, A.2
Lutz, J.3
Leiby, B.4
Bonuccelli, G.5
Lisanti, M.P.6
-
16
-
-
33751252276
-
Cancer metastasis: Building a framework
-
Gupta GP, Massague J, (2006). Cancer metastasis: building a framework. Cell 127: 679-695.
-
(2006)
Cell
, vol.127
, pp. 679-695
-
-
Gupta, G.P.1
Massague, J.2
-
17
-
-
69349095364
-
Anticancer strategies involving the vasculature
-
Heath VL, Bicknell R, (2009). Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 6: 395-404.
-
(2009)
Nat Rev Clin Oncol
, vol.6
, pp. 395-404
-
-
Heath, V.L.1
Bicknell, R.2
-
18
-
-
24744471011
-
Causes and consequences of DNA hypomethylation in human cancer
-
Hoffmann MJ, Schulz WA, (2005). Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83: 296-321.
-
(2005)
Biochem Cell Biol
, vol.83
, pp. 296-321
-
-
Hoffmann, M.J.1
Schulz, W.A.2
-
19
-
-
84891368131
-
Activation of the Wnt pathway through use of AR79, a glycogen synthase kinase 3beta inhibitor, promotes prostate cancer growth in soft tissue and bone
-
Jiang Y, Dai J, Zhang H, Sottnik JL, Keller JM, Escott KJ, et al. (2013). Activation of the Wnt pathway through use of AR79, a glycogen synthase kinase 3beta inhibitor, promotes prostate cancer growth in soft tissue and bone. Mol Cancer Res 11: 1597-1610.
-
(2013)
Mol Cancer Res
, vol.11
, pp. 1597-1610
-
-
Jiang, Y.1
Dai, J.2
Zhang, H.3
Sottnik, J.L.4
Keller, J.M.5
Escott, K.J.6
-
20
-
-
78650308466
-
TGF-beta in cancer and bone: Implications for treatment of bone metastases
-
Juarez P, Guise TA, (2011). TGF-beta in cancer and bone: implications for treatment of bone metastases. Bone 48: 23-29.
-
(2011)
Bone
, vol.48
, pp. 23-29
-
-
Juarez, P.1
Guise, T.A.2
-
21
-
-
77950931419
-
Matrix metalloproteinases: Regulators of the tumor microenvironment
-
Kessenbrock K, Plaks V, Werb Z, (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
-
(2010)
Cell
, vol.141
, pp. 52-67
-
-
Kessenbrock, K.1
Plaks, V.2
Werb, Z.3
-
22
-
-
77954326944
-
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
-
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1577-1579
-
-
Kilkenny, C.1
Browne, W.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
23
-
-
70349784400
-
The role of plasminogen-plasmin system in cancer
-
Kwaan HC, McMahon B, (2009). The role of plasminogen-plasmin system in cancer. Cancer Treat Res 148: 43-66.
-
(2009)
Cancer Treat Res
, vol.148
, pp. 43-66
-
-
Kwaan, H.C.1
McMahon, B.2
-
24
-
-
84863012028
-
Dietary supplementation with S-adenosyl methionine delayed amyloid-beta and tau pathology in 3xTg-AD mice
-
Lee S, Lemere CA, Frost JL, Shea TB, (2012). Dietary supplementation with S-adenosyl methionine delayed amyloid-beta and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28: 423-431.
-
(2012)
J Alzheimers Dis
, vol.28
, pp. 423-431
-
-
Lee, S.1
Lemere, C.A.2
Frost, J.L.3
Shea, T.B.4
-
25
-
-
23144436179
-
Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer
-
Lu SC, Mato JM, (2005). Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 35: 227-234.
-
(2005)
Alcohol
, vol.35
, pp. 227-234
-
-
Lu, S.C.1
Mato, J.M.2
-
26
-
-
68949180034
-
S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model
-
Lu SC, Ramani K, Ou X, Lin M, Yu V, Ko K, et al. (2009). S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology 50: 462-471.
-
(2009)
Hepatology
, vol.50
, pp. 462-471
-
-
Lu, S.C.1
Ramani, K.2
Ou, X.3
Lin, M.4
Yu, V.5
Ko, K.6
-
27
-
-
84885581366
-
S-adenosylmethionine metabolism and liver disease
-
Mato JM, Martinez-Chantar ML, Lu SC, (2013). S-adenosylmethionine metabolism and liver disease. Ann Hepatol 12: 183-189.
-
(2013)
Ann Hepatol
, vol.12
, pp. 183-189
-
-
Mato, J.M.1
Martinez-Chantar, M.L.2
Lu, S.C.3
-
28
-
-
77954331629
-
Guidelines for reporting experiments involving animals: The ARRIVE guidelines
-
McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1573-1576
-
-
McGrath, J.1
Drummond, G.2
McLachlan, E.3
Kilkenny, C.4
Wainwright, C.5
-
29
-
-
73949121977
-
Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells
-
Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV, (2010). Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther 9: 33-45.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 33-45
-
-
Mishra, D.K.1
Chen, Z.2
Wu, Y.3
Sarkissyan, M.4
Koeffler, H.P.5
Vadgama, J.V.6
-
30
-
-
3843125363
-
Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis
-
Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA, (2004). Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 279: 31735-31744.
-
(2004)
J Biol Chem
, vol.279
, pp. 31735-31744
-
-
Pakneshan, P.1
Szyf, M.2
Farias-Eisner, R.3
Rabbani, S.A.4
-
31
-
-
84871842069
-
Folates and S-adenosylmethionine for major depressive disorder
-
Papakostas GI, Cassiello CF, Iovieno N, (2012). Folates and S-adenosylmethionine for major depressive disorder. Can J Psychiatry 57: 406-413.
-
(2012)
Can J Psychiatry
, vol.57
, pp. 406-413
-
-
Papakostas, G.I.1
Cassiello, C.F.2
Iovieno, N.3
-
32
-
-
84891791940
-
The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
-
NC-IUPHAR
-
Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-1106.
-
(2014)
Nucl Acids Res
, vol.42
, Issue.DATABASE ISSUE
, pp. D1098-D1106
-
-
Pawson, A.J.1
Sharman, J.L.2
Benson, H.E.3
Faccenda, E.4
Alexander, S.P.5
Buneman, O.P.6
-
33
-
-
84879968416
-
Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer
-
Richiardi L, Fiano V, Grasso C, Zugna D, Delsedime L, Gillio-Tos A, et al. (2013). Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer. PLoS ONE 8: e68162.
-
(2013)
PLoS ONE
, vol.8
, pp. e68162
-
-
Richiardi, L.1
Fiano, V.2
Grasso, C.3
Zugna, D.4
Delsedime, L.5
Gillio-Tos, A.6
-
34
-
-
33749483782
-
Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo
-
Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA, (2006). Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 66: 9202-9210.
-
(2006)
Cancer Res
, vol.66
, pp. 9202-9210
-
-
Shukeir, N.1
Pakneshan, P.2
Chen, G.3
Szyf, M.4
Rabbani, S.A.5
-
35
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R, Naishadham D, Jemal A, (2013). Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
-
(2013)
CA Cancer J Clin
, vol.63
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
36
-
-
80052423473
-
The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer
-
Song YH, Shiota M, Kuroiwa K, Naito S, Oda Y, (2011). The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer. Mod Pathol 24: 1272-1280.
-
(2011)
Mod Pathol
, vol.24
, pp. 1272-1280
-
-
Song, Y.H.1
Shiota, M.2
Kuroiwa, K.3
Naito, S.4
Oda, Y.5
-
37
-
-
33746851956
-
Tumor metastasis: Mechanistic insights and clinical challenges
-
Steeg PS, (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
-
(2006)
Nat Med
, vol.12
, pp. 895-904
-
-
Steeg, P.S.1
-
38
-
-
41849150003
-
Metastasis: A therapeutic target for cancer
-
Steeg PS, Theodorescu D, (2008). Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5: 206-219.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 206-219
-
-
Steeg, P.S.1
Theodorescu, D.2
-
39
-
-
80052234430
-
Definition of the landscape of promoter DNA hypomethylation in liver cancer
-
Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, et al. (2011). Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 71: 5891-5903.
-
(2011)
Cancer Res
, vol.71
, pp. 5891-5903
-
-
Stefanska, B.1
Huang, J.2
Bhattacharyya, B.3
Suderman, M.4
Hallett, M.5
Han, Z.G.6
-
40
-
-
84902689867
-
Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets
-
Stefanska B, Cheishvili D, Suderman M, Arakelian A, Huang J, Hallett M, et al. (2014). Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Clin Cancer Res 20: 3118-3132.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 3118-3132
-
-
Stefanska, B.1
Cheishvili, D.2
Suderman, M.3
Arakelian, A.4
Huang, J.5
Hallett, M.6
-
41
-
-
79958037582
-
Bone metastasis in prostate cancer: Emerging therapeutic strategies
-
Sturge J, Caley MP, Waxman J, (2011). Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol 8: 357-368.
-
(2011)
Nat Rev Clin Oncol
, vol.8
, pp. 357-368
-
-
Sturge, J.1
Caley, M.P.2
Waxman, J.3
-
42
-
-
78449300594
-
/CXCR4/CXCR7 chemokine axis and cancer progression
-
CXCL12
-
Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, et al. (2010). CXCL12 /CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29: 709-722.
-
(2010)
Cancer Metastasis Rev
, vol.29
, pp. 709-722
-
-
Sun, X.1
Cheng, G.2
Hao, M.3
Zheng, J.4
Zhou, X.5
Zhang, J.6
-
43
-
-
79953078905
-
Bone metastasis: Mechanisms and therapeutic opportunities
-
Suva LJ, Washam C, Nicholas RW, Griffin RJ, (2011). Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7: 208-218.
-
(2011)
Nat Rev Endocrinol
, vol.7
, pp. 208-218
-
-
Suva, L.J.1
Washam, C.2
Nicholas, R.W.3
Griffin, R.J.4
-
44
-
-
84865570978
-
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers
-
Tomasi ML, Tomasi I, Ramani K, Pascale RM, Xu J, Giordano P, et al. (2012). S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology 56: 982-993.
-
(2012)
Hepatology
, vol.56
, pp. 982-993
-
-
Tomasi, M.L.1
Tomasi, I.2
Ramani, K.3
Pascale, R.M.4
Xu, J.5
Giordano, P.6
-
45
-
-
0026649374
-
The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets
-
Zapisek WF, Cronin GM, Lyn-Cook BD, Poirier LA, (1992). The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 13: 1869-1872.
-
(1992)
Carcinogenesis
, vol.13
, pp. 1869-1872
-
-
Zapisek, W.F.1
Cronin, G.M.2
Lyn-Cook, B.D.3
Poirier, L.A.4
|